DexCom, Inc.DXCMNASDAQ

|||

Overview News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 92% recommend buying.

Consensus Rating

Buy

25 analysts·High coverage

92%

Rating Distribution

Strong Buy

14%

Buy

2288%

Hold

28%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 27% higher.

Bear Case

$75.00

+11%

Consensus

$85.36

+27%

Bull Case

$99.00

+47%

Price Range25 analysts

Low

Consensus

High

$75.00

$99.00

Current Target

Current Price

$67.40

Upside to Target

$17.96

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$2.47(16 analysts)

P/E37x

Current: 36.6x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+12.74%

EPS+20.84%

FY2028

Rev+14.23%

EPS+23.60%

FY2029

Rev+12.70%

EPS+18.39%

Earnings Surprises

Beat rate:83%(10/12 quarters)

Avg surprise:+16.0%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 9, 2026Bernstein

DexCom price target raised to $86 from $84 at Bernstein

Target:$86.00

+25.7%from $68.43

Dec 17, 2025Mizuho Securities

DexCom price target raised to $78 from $75 at Mizuho

Target:$78.00

+17.5%from $66.37

Dec 16, 2025Leerink Partners

DexCom (DXCM) PT Raised to $92 at Leerink Partners

Target:$92.00

+40.7%from $65.38

Dec 2, 2025Morgan Stanley

DexCom upgraded to Overweight from Equal Weight at Morgan Stanley

Target:$75.00

+18.1%from $63.52

Nov 10, 2025Morgan Stanley

DexCom price target lowered to $63 from $89 at Morgan Stanley

Target:$63.00

+14.1%from $55.21

Nov 3, 2025Bernstein

'DexCom (DXCM) Too Cheap to Ignore'; Stock PT Lowered at Bernstein

Target:$84.00

+44.3%from $58.22

Nov 3, 2025Barclays

DexCom price target lowered to $80 from $98 at Barclays

Target:$80.00

+37.4%from $58.22

Oct 31, 2025Piper Sandler

DexCom (DXCM) PT Lowered at Piper Sandler; 'We Strongly Recommend Investors Buy the Stock'

Target:$75.00

+31.6%from $56.97

Oct 31, 2025RBC Capital

DexCom price target lowered to $85 from $100 at RBC Capital

Target:$85.00

+49.3%from $56.95

Oct 31, 2025Robert W. Baird

DexCom price target lowered to $82 from $90 at Baird

Target:$82.00

+38.5%from $59.19

Oct 31, 2025Wells Fargo

DexCom price target lowered to $93 from $98 at Wells Fargo

Target:$93.00

+36.4%from $68.20

Oct 31, 2025Canaccord Genuity

DexCom price target lowered to $99 from $106 at Canaccord

Target:$99.00

+45.2%from $68.20

Oct 21, 2025Piper Sandler

Piper Sandler Sees Good Setup for DexCom (DXCM) Stock, Recommends Purchase

Target:$100.00

+46.1%from $68.44

Oct 15, 2025Truist Financial

DexCom price target lowered to $94 from $102 at Truist

Target:$94.00

+43.4%from $65.55

Sep 26, 2025Robert W. Baird

DexCom price target lowered to $90 from $112 at Baird

Target:$90.00

+31.8%from $68.30

Oct 8, 2024RBC Capital

DexCom price target lowered to $120 from $130 at RBC Capital

Target:$120.00

+74.9%from $68.62

Aug 22, 2024Stifel Nicolaus

DexCom price target raised to $100 from $90 at Stifel

Target:$100.00

+38.4%from $72.28

Aug 16, 2024RBC Capital

DexCom price target lowered to $130 from $145 at RBC Capital

Target:$130.00

+79.7%from $72.36

Jul 29, 2024Barclays

DexCom price target lowered to $113 from $138 at Barclays

Target:$113.00

+76.6%from $64.00

Jul 26, 2024Oppenheimer

DexCom price target lowered to $115 from $150 at Oppenheimer

Target:$115.00

+6.6%from $107.85

Jul 26, 2024Piper Sandler

DexCom (DXCM) PT Lowered to $90 at Piper Sandler

Target:$90.00

+42.4%from $63.22

Jul 26, 2024Canaccord Genuity

DexCom price target lowered to $89 from $145 at Canaccord

Target:$89.00

-17.5%from $107.85

Jul 26, 2024RBC Capital

DexCom (DXCM) PT Lowered to $145 at RBC Capital

Target:$145.00

+356.4%from $31.77

Jul 12, 2024Stifel Nicolaus

DexCom price target lowered to $132 from $145 at Stifel

Target:$132.00

+17.2%from $112.66

Jun 3, 2024Oppenheimer

Oppenheimer Reiterates Outperform Rating on DexCom (DXCM)

Target:$150.00

+30.2%from $115.23

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance